STRS Ohio’s Niagen Bioscience NAGE Stock Holding History

STRS Ohio’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-41,900	Closed	-$266K	–	2238
2025 Q4	$266K	Hold	41,900	–	–	﹤0.01%	1384
2025 Q3	$391K	Hold	41,900	–	–	﹤0.01%	1214
2025 Q2	$604K	Buy	41,900 +7,700	+23%	+$76K	﹤0.01%	1127
2025 Q1	$236K	Sell	34,200 -61,500	-64%	-$386K	﹤0.01%	1471
2024 Q4	$508K	Sell	95,700 -8,400	-8%	-$46K	﹤0.01%	1197
2024 Q3	$380K	Hold	104,100	–	–	﹤0.01%	1368
2024 Q2	$284K	Buy	+104,100	New	+$348K	﹤0.01%	1459
2022 Q2	–	Sell	-14,600	Closed	-$35K	–	2334
2022 Q1	$35K	Hold	14,600	–	–	﹤0.01%	1991
2021 Q4	$54K	Hold	14,600	–	–	﹤0.01%	1995
2021 Q3	$91K	Sell	14,600 -14,300	-49%	-$118K	﹤0.01%	1957
2021 Q2	$284K	Sell	28,900 -6,900	-19%	-$60.2K	﹤0.01%	1731
2021 Q1	$334K	Sell	35,800 -59,600	-62%	-$472K	﹤0.01%	1688
2020 Q4	$457K	Buy	95,400 +16,800	+21%	+$81.9K	﹤0.01%	1515
2020 Q3	$315K	Buy	+78,600	New	+$379K	﹤0.01%	1550
2016 Q4	–	Sell	-9,200	Closed	-$27K	–	2000
2016 Q3	$27K	Sell	9,200 -300	-3%	-$1.1K	﹤0.01%	1824
2016 Q2	$39K	Buy	+9,500	New	+$44.9K	﹤0.01%	1808

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

STRS Ohio's NAGE Position: Q1 2026 in Review

STRS Ohio sold out of Niagen Bioscience (NAGE) in Q1 2026, closing a stake of 41,900 shares — an estimated $266K sold.

STRS Ohio first reported a position in NAGE in Q2 2016 and held it in 16 quarters. The position peaked at $604K in Q2 2025. 143 funds tracked by Wall St. Rank hold NAGE as of Q1 2026.

STRS Ohio reported no remaining Niagen Bioscience position as of Q1 2026 after selling out during the quarter.
STRS Ohio sold 41,900 Niagen Bioscience shares in Q1 2026, an estimated $266K.
STRS Ohio first reported a position in Niagen Bioscience in Q2 2016 and held it in 16 quarters.
STRS Ohio's Niagen Bioscience position peaked at $604K in Q2 2025.
143 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.